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Abstract 
Purpose: Ventilation–perfusion single-photon emission computed tomography (VP 
SPECT) plays an important role in pulmonary embolism diagnosis. Rapid results may 
be obtained using same-day ventilation followed by perfusion imaging, but generally 
requires careful attention to achieving an optimal count rate ratio (P/V ratio) of ≥ 3:1. 
This study investigated whether the ratio of counts simultaneously acquired in adja-
cent primary and Compton scatter energy windows (Eratio) on V SPECT was predictive 
of final normalised perfusion count rate  (PCRnorm) on P SPECT using  [
99mTc]Tc-macroag-
gregated albumin (MAA), thus allowing for optimisation of P/V ratios.
Methods: Same-day VP SPECT studies acquired using standard protocols in adult 
patients during a 2-year period (training dataset) were assessed. Studies were included 
provided they were acquired with correct imaging parameters, and injection site imag-
ing and laboratory records were available for quality control and normalised count rate 
corrections. Extraction of DICOM information, and linear regression were performed 
using custom Python and R scripts. A predictive tool was developed in Microsoft Excel. 
This tool was then validated using a second (validation) dataset of same-day stud-
ies acquired over a subsequent 7-month period. Accuracy of the prediction tool was 
assessed by calculating the mean absolute percentage error (MAPE).
Results: Of 643 studies performed, the scans of 342 participants (median age 
30.4 years, 318 female) were included in the training dataset, the analysis of which 
yielded a significant regression equation (F(1,340) = 1057.3, p < 0.0001), with an 
adjusted R2 of 0.756 and MSE of 0.001089. A prediction tool designed for routine clini-
cal use was developed for predicting final P/V ratio. Of an additional 285 studies, 198 
were included in the second (validation) dataset (median age 29.7 years, 188 female). 
The Excel-based tool was shown to be 91% accurate (MAPE: 9%) in predicting P/V ratio.
Conclusion: The relationship between the ratio of simultaneously acquired counts 
in adjacent energy windows on V SPECT and perfusion count rate after administra-
tion of a known activity of  [99mTc]Tc-MAA can be linearly approximated. A predictive 
tool based on this work may assist in optimising the dose and timing of  [99mTc]Tc-MAA 
administration in same-day studies to the benefit of patients and workflows.
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Introduction
The perfusion component of a ventilation–perfusion single-photon emission com-
puted tomography (VP SPECT) study is typically undertaken on the same day as, and 
frequently immediately following the ventilation component. When using technetium-
99m (99mTc)-based radiopharmaceuticals in a same-day imaging strategy (generally rec-
ommended, especially to obtain rapid diagnosis of pulmonary embolism) [1], residual 
ventilation counts contribute to the acquired perfusion images and may obscure perfu-
sion defects leading to misdiagnosis. While software can perform correction for residual 
ventilation counts in the final perfusion image, slight differences in radiopharmaceuti-
cal distributions, and imperfect co-registration can lead to significant artefacts, and it 
is therefore recommended that the perfusion count rate (PCR—corrected for residual 
ventilation counts) exceeds the ventilation count rate (VCR) by a factor of at least 3 
[2–4]. This is the equivalent, when a perfusion SPECT is performed immediately after 
the ventilation SPECT, of the uncorrected count rate exceeding the VCR by a minimum 
factor of 4. At the same time, higher ratios may also be considered undesirable since 
these would require high doses of the perfusion radiopharmaceutical  [99mTc]Tc—mac-
roaggregated albumin  ([99mTc]Tc-MAA), which would result in higher radiation dose, 
and increased risks posed by the administration of a higher number of  [99mTc]Tc-MAA 
particles. The former is especially relevant in VP SPECT studies performed to diagnose 
pulmonary embolism (PE) in pregnant or lactating women in whom radiation exposure 
poses an additional risk; while the latter is relevant especially when administering  [99mTc]
Tc-MAA in patients with known or occult disorders of the pulmonary vasculature.
The targeting of an optimal perfusion/ventilation count rate ratio (P/V ratio) is com-
plicated principally by the fact that it is often difficult to quantify the amount of ventila-
tion activity that has been administered in any individual patient. In patients with a large 
amount of soft tissue, higher amounts of administered activity may be required to obtain 
a sufficiently high VCR to guarantee a ventilation SPECT of sufficient quality. This is 
mainly because as the amount of soft tissue increases, there is increased attenuation due 
to Compton scatter [5]. Post hoc calculation of administered ventilation activity using 
knowledge of the imaging system sensitivity alone is not possible due to the frequently 
significant amount of attenuation by thoracic tissue. While absolute quantification 
of administered ventilation activity is possible using quantitative SPECT, this remains 
experimental and requires specialised software and a SPECT/CT system [6]. As a result, 
the dose and timing of  [99mTc]Tc-MAA administration after the ventilation SPECT is 
frequently suboptimal, resulting in PCRs that are either too low to achieve an adequate 
P/V ratio, or the administration of activities exceeding those recommended or required, 
and thus not meeting the principle of “as low as reasonably achievable” (ALARA).
It is possible to account for photon attenuation using information from a second, 
simultaneously acquired Compton scatter window [7]. Using various techniques in 
phantom-based studies, researchers have demonstrated linear relationships between the 
number of photons detected in scatter windows and voxel attenuation coefficients [8] or 
attenuation depth [9].
This study aimed to investigate whether a simple ratio of counts acquired in two adja-
cent energy windows on the ventilation SPECT (Eratio) is predictive of the final perfusion 
count rate normalised for  [99mTc]Tc-MAA activity  (PCRnorm) on the perfusion SPECT; 
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and if so, whether such a relationship can be used to develop a simple tool to adjust 
either the activity (dose) of  [99mTc]Tc-MAA administered or the timing (or both) of the 
perfusion SPECT, such that an optimal P/V ratio may be achieved.
Material and methods
Participant selection
All patients referred to the Tygerberg Hospital Division of Nuclear Medicine for VP 
SPECT studies between July 2017 and July 2019 were eligible for inclusion. Only patients 
with same-day studies (ventilation followed by perfusion) and who were older than 
18  years were included in this retrospective analysis. Patients in whom no  [99mTc]Tc-
MAA injection site imaging was performed; or for whom the  [99mTc]Tc-MAA dispensing 
time was not recorded (to correct  [99mTc]Tc-MAA dose for residual counts at adminis-
tration site, and for decay) were excluded, as were the scans of patients in whom the 
imaging acquisition differed from the divisional protocol; or in cases in which a repeat 
SPECT acquisition was performed. A second sample (validation dataset), subsequently 
drawn from scans performed between July 2019 and March 2020, with the same inclu-
sion and exclusion criteria, was prepared to validate the tool developed with the original 
sample (training dataset).
Imaging procedure
Ventilation was performed with the patient lying supine, using a  [99mTc]Tc-Technegas 
generator (Vita Medical Ltd, Lucas Heights, New South Wales, Australia). After each 
breath, tubing of the ventilation system was set aside and a Geiger-Müller (GM) detector 
(Radiation Alert® – Inspector, SE International Inc, Summertown, TN, USA) positioned 
on the sternum. Technicians were instructed to target an approximate stabilised probe 
count rate of ~ 2500 counts per minute (cpm). Immediately after ventilation, SPECT was 
performed on a dual-head Siemens Symbia SPECT camera (Siemens Healthineers, Hoff-
man Estates, IL, USA) with measured detector energy resolution of 8.5%, or a dual-head 
GE Infinia Hawkeye SPECT-CT camera (General Electric Medical Systems, Milwaukee, 
WI, USA) with measured detector energy resolution of 11.1%. Acquisition protocols 
(Table 1) were chosen to match most closely those recommended by Palmer et al. [4]. All 
SPECT scans were acquired with a primary energy window centred on a peak of 140 keV 
(width ± 7.5%); and a symmetrical down-scatter window, centred on a peak of 119 keV, 
of exactly the same width immediately beneath this. The latter window has been rou-
tinely included in VP SPECT acquisitions in the Tygerberg Division of Nuclear Medicine 
since 2015, at which time image reconstruction software (Hermes Gold 3; Nuclear Diag-
nostics, Stockholm Sweden) used this data to construct a synthetic attenuation map.
The perfusion study was acquired either immediately after the ventilation study or 
after a delay to allow for some decay of ventilation counts using ~ 120 MBq of  [99mTc]
Tc-MAA (Pulmocis®, Cisbio). All dispensed  [99mTc]Tc-MAA doses had a radiochemi-
cal purity of ≥ 95%. Static acquisitions (64 × 64 matrix, 60 s, 129.5–150.5 keV), using the 
same LEAP collimator as used for SPECT, were made of the  [99mTc]Tc-MAA injection 
site to exclude major misinjection and to quantify residual activity in the injection por-
tal. Residual activity in the syringe was not measured.
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Data extracted from DICOM files and paper records
From the radiopharmacy and patient scan records, the time  [99mTc]Tc-MAA was dis-
pensed and the activity at dispense time were recorded.
All raw tomographic VP SPECT image data, as well as corresponding injection site 
images for the periods in question were downloaded from the divisional PACS in 
DICOM format.
A custom script written in Python version 3.8.2 [10] using the pydicom package ver-
sion 1.4.2 [11] was used to extract information from the DICOM image and header tags, 
both to assure compliance with divisional acquisition protocols, and to obtain the neces-
sary image measures for analysis purposes.
Information to ensure consistency of the acquisition protocols included width and 
centring of the energy windows; scan arc; number of frames; frame duration; and cam-
era and collimator identifiers. Scan order (ventilation followed by perfusion) was also 
validated by checking scan dates and times.
Measures extracted for analysis purposes included patient name, surname, and folder 
number (subsequently deidentified); patient gender and date of birth (for demographic 
purposes); scan dates and times (for decay correction); and total image counts for both 
energy windows (for tomographic data) or in the primary energy window for the injec-
tion site images.
Derived image measures and how they were calculated are summarised in Table 2.
Modelling
Based on visual analysis of the initial scatter plot of the training dataset, a linear regres-
sion model of Eratio and  PCRnorm was built in RStudio version 1.3.1093 [12] using R 
Table 1 SPECT acquisition parameters
LEAP, Low-energy, all purpose; keV, kiloelectron volts; sec, seconds






Collimator sensitivity (measured) (cps/MBq) 133 119
Matrix 64 × 64 64 × 64
Zoom 1.45 1.3
Pixel size (mm) 6.8 6.8
Primary energy window centre (keV) 140 140
Primary energy window lower threshold (keV) 129.5 129.5
Primary energy window upper threshold (keV) 150.5 151
Secondary energy window centre (keV) 119 119
Secondary energy window lower threshold (keV) 108.5 108.5
Secondary energy window upper threshold (keV) 129.5 129.5
Frames 120 120
Angle step (degrees) 3 3
Rotation (degrees) 360 360
Frame duration ventilation SPECT (sec) 10 12
Frame duration perfusion SPECT (sec) 5 5
Page 5 of 15Doruyter and Holness  EJNMMI Phys            (2021) 8:69  
version 4.0.2 [13]. Diagnostic plots were generated using native, ggfortify [14], and nort-
est packages. A threshold of p = 0.05 was considered statistically significant. Calculation 
of 95% prediction intervals for graphing purposes was performed using the native pre-
dict.lm function. Normality of the residuals was assessed using graphical methods.
Prediction tool
Using the results of the linear regression performed on the training dataset, and the 
mean squared error (MSE), a tool to predict final P/V ratio was developed in Microsoft® 
Excel® for Microsoft 365 MSO (16.0.13127.20620) 64-bit.
Validation
Validation of the Excel-based tool was performed by comparing the model-predicted 
P/V ratio values with the actual P/V ratios for studies in the validation dataset. Accuracy 
of the model in predicting P/V ratio was assessed by calculating the mean absolute per-
centage error (MAPE) using the MLmetrics package in R.
Table 2 Derived image measures
* Reported in Results section
Measure (unit) Formula Description






Eratio was calculated by summing the counts of all projections 
in the primary energy window of the raw ventilation SPECT 
data ( v1 ), and then dividing the result by the summed counts 
of all projections in the Compton scatter energy window of 
the raw ventilation SPECT data ( v2)




t1 The ventilation count rate (VCR) was calculated by summing 
the counts of all projections in the primary energy window 
of the raw ventilation SPECT data ( v1 ), and then dividing the 
result by the ventilation SPECT acquisition duration ( t1)




t2 The perfusion + ventilation count rate (PVCR) was calculated 
by summing the counts of all projections in the primary 
energy window of the raw perfusion SPECT data ( p1 ), and 
then dividing the result by the perfusion SPECT acquisition 
duration ( t2)
PCR (cps) PCR = PVCR− DF · VCR The perfusion count rate (PCR) was calculated by first correct-
ing VCR by the relevant decay factor [ DF ] to account for the 
interval between ventilation and perfusion SPECTs, and then 
subtracting the result from PVCR





The P/V ratio was calculated by dividing PCR by VCR
Ainj (MBq) Ainj = DF · ICR/S The activity of  [
99mTc]Tc-MAA present at the injection site at 
time of P SPECT (Ainj) was calculated by taking the count rate 
on the injection site planar static image (ICR), correcting this 
value by the relevant decay factor [ DF ] to account for the 
interval between perfusion SPECT and injection site imaging, 
and then dividing the result by camera-collimator sensitivity 
( S)
Asys (MBq) Asys = DF · Adisp − Ainj The activity of  [
99mTc]Tc-MAA administered systemically at 
the time of the perfusion SPECT (Asys) was calculated by first 
correcting the amount of activity at time of dispensing (Adisp) 
by the relevant decay factor [DF] to account for the interval 
between dispensing and perfusion SPECT, and then subtract-
ing Ainj
PCRnorm (arb. unit)* prate = PCRAsys /S
The normalised perfusion count rate  (PCRnorm) was calculated 
by dividing PCR by Asys, and then dividing the result by the 
camera-collimator sensitivity (S)
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Clinical impact
The practical implications of using the tool on studies included in the validation dataset 
was also simulated for a sample strategy that favoured dose sparing. First, VCR values 
were normalised such that the summed ventilation counts equalled the recommended 
value of 2 million [4]. Because the actual PCR per MBq of administered  [99mTc]Tc-MAA 
could be retrospectively calculated, it was possible to (1) calculate the  [99mTc]Tc-MAA 
dose that would have been required to achieve a minimum P/V ratio of 3 had the perfu-
sion component immediately followed the ventilation component (i.e. no delay), and (2) 
to calculate the true delay that would have been required after an optimal ventilation 
study before it would have been possible to proceed with a target dose (120  MBq) of 
 [99mTc]Tc-MAA and still achieve an adequate P/V ratio. These results were then com-
pared to the delay recommended by the prediction tool, assuming a  [99mTc]Tc-MAA 
dose of 120 MBq and the same minimum P/V ratio. The 120 MBq target dose is the same 
as that recommended in a same-day protocol in pregnant patients [15] and provides a 
margin of safety should the actual dose required while injecting under the detector be 
greater (up to the limit of 185 MBq according to the package insert for the Pulmocis® 
product). By comparing the true delay required and the predicted delay required, unnec-
essary delay (delay suggested by model exceeding actual delay required) and insufficient 
delay (delay suggested by model inadequate) could also be quantified. Benefits of using 
the prediction tool were quantified in terms of dose of  [99mTc]Tc-MAA spared. Costs of 
using the prediction tool were quantified in terms of unnecessary delay. Since the dem-
onstration of clinical impact was performed purely for illustrative purposes using one 
of many possible strategies, confidence intervals for the predicted delays required were 




A total of 643 studies (ventilation SPECT followed by same-day perfusion SPECT) were 
identified in the study period. Of these, 22 were of patients under the age of 18 years 
and were excluded. An additional 199 studies were excluded due to missing injection 
site image; one significant misinjection (83  MBq); 69 due to missing radiopharmacy 
records  ([99mTc]Tc-MAA dispense time not recorded); four due to incorrect dispense 
time records (recorded time later than scan time); and one due to deviation from the 
divisional protocol (incorrect collimator used). Four participants had repeat studies 
(10.1–58.6 weeks later), and for these participants, only the first study was included in 
the analysis. An initial analysis was performed on 343 imaging studies. One imaging 
study was retrospectively excluded after it became apparent that it was an outlier with 
high influence and an obvious cause was identified (details below). The sample size for 
the final analysis of the training dataset was thus of 342 imaging studies.
Validation dataset
A total of 285 additional same-day studies were identified in the second period for use in 
the validation dataset. Of these, six were of patients under the age of 18 years and were 
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excluded. An additional 71 studies were excluded due to missing radiopharmacy records 
 ([99mTc]Tc-MAA dispense time not recorded); eight due to incorrect dispense time records 
(recorded time later than scan time); one significant misinjection (36 MBq); and one due to 
a missing injection site image. No participants in this sample had repeat studies. The sam-
ple size for the validation dataset was thus 198 studies.
Demographics and summary statistics
Of the 342 imaging studies included in the final analysis of the training dataset, 317 were 
performed in female patients. The median patient age was 30.1 years (IQR: 25–37.2 years). 
Mean Asys was 114.8 MBq (SD: 8 MBq). Mean Eratio was 1.83 (SD: 0.21), and mean  PCRnorm 
was 0.313 (SD 0.067). Mean P/V ratio was 4.01 (SD 1.09).
Of the 198 imaging studies included in the final analysis of the validation dataset, 188 
were performed in female patients. The median patient age was 29.7  years (IQR: 24.6–
37.5 years). Mean Asys was 118.4 MBq (SD: 9.9 MBq). Mean Eratio was 1.8 (SD: 0.23), and 
mean  PCRnorm was 0.311 (SD 0.072). Mean P/V ratio was 4.98 (SD 1.44).
A breakdown of the final P/V ratio values in the training and validation datasets appears 
in Table 3.
Linear regression
A simple linear regression of the training data was calculated to predict  PCRnorm, given 
Eratio. The initial scatter plot and diagnostic charts (Additional file 1: Fig. S1) identified an 
obvious outlier (datapoint 223: x = 1.89, y = 0.62). Further investigation revealed that the 
ventilation SPECT in this case had a very high amount of activity outside of the patient 
which very likely influenced the Eratio value (Additional file 2: Fig. S2). Given that this obser-
vation was both an outlier and highly influential, and because an obvious cause was identi-
fied on review of the raw data, this observation was retrospectively excluded.
After exclusion of the outlier, a significant regression equation was found 
(F(1,340) = 1057.3, p < 0.0001), with an adjusted R2 of 0.756 and MSE of 0.001089. After 
adjusting for any specific camera-collimator sensitivity factor, the relationship to yield a re-
normalised (adjusted) perfusion count rate was represented by the following equation:
PCR = A× S × (0.28(Eratio)− 0.198)
Table 3  P/V ratio values of the studies included in the training and validation datasets
P/V  ratio Training dataset Validation dataset
Number of studies (%) Number of studies (%)
1–2 7 (2%) 0 (0%)
2–3 52 (16%) 4 (2%)
3–4 114 (34%) 57 (29%)
4–5 105 (31%) 50 (25%)
 > 5 56 (17%) 87 (44%)
Total 343 (100%) 198 (100%)
Page 8 of 15Doruyter and Holness  EJNMMI Phys            (2021) 8:69 
where PCR represents the expected perfusion count rate (in cps), for any administered 
activity (A) of  [99mTc]Tc-MAA (in MBq), re-normalised (adjusted) to account for the 
user-specific sensitivity of the camera-collimator combination S , and predicted by Eratio.
The final model, including confidence and prediction intervals is plotted in Fig. 1. The 
relevant diagnostic plots for the final regression appear in Additional file 3: Fig. S3 and 
Additional file 4: Fig. S4.
Prediction tool
The output of the linear regression enables calculation of the prediction interval around 
y, for any future value of x using the equation:
where ŷ is the predicted fitted value of y for a particular value of x ; t( α
2
,n−2) represents the 
two-tailed inverse of the Student’s t distribution with significance level α for n number of 
observations in the regression dataset; MSE is the mean squared error; xh is the value of 
a hypothetical future observation of x ; x̄ is the mean value of x in the regression dataset; 
and xi represents the respective values of x in the regression dataset [16].
Using the above formula, a practical tool to predict the final P/V ratio (with 90% and 
95% prediction intervals) was developed in Excel (Additional file 6). A video demonstrat-



















Fig. 1 Final linear regression of perfusion count rate normalised to 1 MBq of administered  [99mTc]Tc-MAA, 
and a camera-collimator sensitivity of 1 cps/MBq  (PCRnorm) as a function of the dual energy window count 
ratio of the ventilation study (Eratio). Regression line (blue solid line), 95% confidence band (dark grey), and 
95% prediction bands (red dashed lines). Image generated in RStudio 
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Validation
A scatter plot of predicted P/V ratios for the validation dataset overlayed on the linear 
model developed using the training dataset is shown in Fig. 2. A plot comparing actual 
P/V ratios to predicted values appears in Fig. 3. The prediction tool was 91% accurate in 
predicting P/V ratios in the validation dataset (MAPE of 9%).
Clinical impact
In the simulation using data from the validation dataset, had the  [99mTc]Tc-MAA dose 
been injected blindly (without using the prediction tool) immediately after an optimal 
ventilation study, the required activity would have exceeded the target dose of 120 MBq 
in 56/198 cases, of which seven would have exceeded the maximum recommended dose 
of 185 MBq.
A breakdown of the impact of using the prediction tool is shown in Fig. 4. Overall, use 
of the prediction tool would have delayed the perfusion study in 62 patients resulting 
in a dose sparing of 0.7–73.5 (median 19.7) MBq at a cost of 3.2–158.6 (median 20.2) 
minutes. Following the recommendation of the prediction tool would have resulted in 14 
additional patients requiring a  [99mTc]Tc-MAA dose less than 120 MBq and six patients 
being spared excessive doses above 185 MBq.
Discussion
This study found that the relationship between the ratio of ventilation counts in the 
primary energy window and an adjacent Compton scatter window and the final perfu-
sion count rate after the administration of a given dose of  [99mTc]Tc-MAA could be 
Fig. 2 Final linear regression as shown in Fig. 1, with training dataset values in grey and superimposed 
validation dataset values in blue. Image generated in RStudio 
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linearly approximated. Results of the analysis were used to develop a practical, Excel-
based tool to predict the adequacy of the P/V ratio in same-day VP SPECT studies, 
which nuclear medicine practitioners can use to optimise the trade-offs that must 
frequently be made in these studies. This tool was validated using a second, training 
dataset and found to be accurate in predicting final P/V ratio. The clinical impact of 
using the tool was illustrated using a dose-sparing strategy.
In a same-day VP SPECT study, the ventilation component is followed (ideally 
immediately after) by the perfusion component. Different strategies are used to 
increase the likelihood of obtaining ventilation images that are of sufficiently high 
diagnostic quality, while still meeting a final target P/V ratio of ≥ 3, and adhering to 
recommended  [99mTc]Tc-MAA doses. Most divisions target a specific count rate (e.g. 
2000–2500 cpm) [17, 18] measured using a GM detector after ventilation, and having 
achieved this, proceed to ventilation imaging. Depending on the count rate on the 
final ventilation SPECT, centres either proceed immediately with injection of  [99mTc]
Tc-MAA under the camera detector, usually checking for or titrating to a fourfold 
increase in count rate, or delay the perfusion component of the study until such a 
time that ventilation count rate is judged to have sufficiently decayed.
There are several problems with these strategies. Foremost, that the VCR is attenu-
ated by variable amounts of soft tissue. This has the effect that a given activity (e.g. 
Fig. 3 Scatter plot of P/V ratio values predicted with the Excel-based tool versus actual values (validation 
dataset). The straight line indicates points for which P/V ratio predicted = P/V ratio actual. Image generated in 
RStudio 
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40 MBq) of administered ventilation agent might result in a very high VCR (in a thin 
patient with minimal attenuating soft tissue), or a very low VCR (in a patient with 
more thoracic soft tissue), typically requiring the additional administration of venti-
lation agent. Very high count rates on the final ventilation study may lead to unnec-
essary deferment of the perfusion study in the first patient (in whom immediately 
proceeding with, e.g. a 120  MBq dose of  [99mTc]Tc-MAA might in actual fact have 
been sufficient), or lead to an inadequate P/V ratio in the second patient (who might 
require, e.g. 80  MBq of administered ventilation agent to achieve adequate ventila-
tion counts) when their perfusion study is undertaken immediately, even with the 
maximum  [99mTc]Tc-MAA dose of 185 MBq recommended by the Pulmocis® pack-
age insert. Titrating the dose of  [99mTc]Tc-MAA administered to count rate under 
the camera is a useful compromise [19] but may require excessive amounts of activ-
ity (and particles) with attendant risks. It may be speculated that the difficulties in 
optimising the trade-offs between dose, count adequacy, sufficient P/V ratio, and rea-
sonable patient turnaround times, are greatest in units caring for patients with wide 
variability in body habitus. Certainly, these trade-offs are frequently imperfect: a mul-
ticentre survey including the results of 286 VP SPECT studies in Germany reported 
inadequate P/V ratios in 25% of studies [19] which is similar to the findings of the 
current study, in which 18% of studies in the training dataset did not meet the recom-
mended P/V ratio of > 3.
A P/V ratio that is too high is also problematic. While the optimal P/V ratio is uncer-
tain, it seems unlikely that much additional diagnostic benefit is achieved with ratios 
Fig. 4 Results of applying the prediction tool to ventilation studies in the validation dataset using a 
dose-sparing strategy (targeting a  [99mTc]Tc-MAA dose of 120 MBq, and a P/V ratio of 3). In the stimulation, 
values predicted by the tool were compared to equivalent values calculated directly from actual perfusion 
data
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above 5 (44% of cases in the validation dataset). While  [99mTc]Tc-MAA is generally 
accepted as a safe compound, it is not entirely innocuous, with reports of respiratory 
complications and death when high particle numbers have been administered to patients 
with underlying pathology of the pulmonary vasculature [20–23]. The risks posed by 
exposure to low doses of ionising radiation are more controversial [24, 25] but certainly 
it is reasonable to try and minimise the risks conferred by both particle number and 
radiation when reasonably achievable.
Most SPECT cameras can be easily configured to simultaneously image two adjacent 
energy windows. Once the ventilation SPECT is complete, it is a simple matter to per-
form a quick quality check of the raw data, and to use the perfusion adequacy prediction 
tool to predict the final P/V ratio. Moreover, this tool allows users to prioritise lower 
radiation dose or higher scan quality by modelling the impacts of different  [99mTc]Tc-
MAA doses and/or delays before performing the perfusion SPECT on the P/V ratio.
Compton scatter is the predominant mode of gamma photon interaction with matter 
when imaging with  [99mTc]Tc-based tracers and increases as the depth of attenuating soft 
tissue increases [9]. This is evidenced by plotting Eratio values against body mass index (a 
crude measure of body habitus) for a subset (n = 291) of participants from the training 
dataset in whom this information was available (Additional file  5: Fig. S5a). This also 
explains why Eratio for any individual patient is constant, independent on the amount of 
administered activity (dose) since the attenuation profile remains constant—illustrated 
by plotting Eratio values derived from the V SPECT study with Eratio values derived from 
the corresponding VP SPECT for the combined dataset (Additional file 5: Fig. S5b).
A linear model to describe the relationship between Eratio and  PCRnorm was selected 
based on the scatter plot of data in the training dataset but the basis for such a rela-
tionship is uncertain. Researchers have previously demonstrated an approximately linear 
relationship between scatter fraction and attenuation: Sitek et al. demonstrated a linear 
relationship between the proportion of singly scattered photons and voxel attenuation 
coefficients, which they used to calculate mu-maps in a  [99mTc]Tc torso phantom study 
[8]. Similarly, also using phantoms, another group showed that ratios of scatter photons 
to photons detected in the primary energy window can be linearly correlated with tissue 
depth [9]. These linear relationships, assuming they translate to real world conditions, 
would however still not explain a linear relationship between Eratio (calculated on the 
ventilation study raw data) and PCR in the current study, since the latter would still be 
subject to the phenomenon of exponential attenuation of photon transmission in broad 
beam conditions. Rather, it is speculated that the relationship is in fact exponential, and 
that the success of the linear model in this study is because a linear approximation is suf-
ficiently accurate over the range of tissue depths encountered in the sample (not quanti-
fied in this experiment).
In addition to enabling the validation of the model, the second dataset allowed a simu-
lation of clinical impact when using the prediction tool. For the purpose of illustration, 
a dose-sparing strategy was chosen, mimicking the preferred practice of the Tygerberg 
Hospital Division of Nuclear Medicine. It is however important to emphasise that the 
trade-off between dose and delay can be set to any user’s institutional or personal prefer-
ence when using the tool. Using a dose-sparing strategy in this simulation, compared to 
values derived from the actual measures, the Excel-based tool would have appropriately 
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deferred the majority of perfusion studies that would otherwise have required activities 
of  [99mTc]Tc-MAA exceeding the target dose of 120 MBq, including those exceeding the 
185 MBq maximum limit recommended by the manufacturer, and this would have been 
achieved with only the minimal cost of excessive delay in a few cases.
This study suffered from several limitations. Many scans had to be excluded from the 
analysis due to missing injection site imaging or radiopharmacy records, which affected 
the final sample size. The sample was mostly composed of young (adult), pregnant 
women which means that caution should be exercised when applying the results to other 
patient demographics, although no reason for deviation from the model is expected on 
in other patient groups. More importantly, the linear relationship between Eratio and 
 PCRnorm at extreme values of Eratio was based on only a few observations, and the validity 
of the linear model at these extremes is less certain. Confidence and prediction inter-
vals may have been narrower had this study included additional corrections potentially 
affecting the accurate calculation of the amount of systemically administered  [99mTc]Tc-
MAA(Asys): (a) for residual activity in the syringe after administration, and (b) for the 
interval between injection and the perfusion SPECT. The latter limitation is however not 
expected to be a major contributor to error, given the divisional policy of commenc-
ing the perfusion SPECT immediately post-injection. Additional sources of error not 
accounted for include non-correction for out-of-field-of-view scatter, and variation in 
the radiochemical purity of  [99mTc]Tc-MAA between 95 and 100% (which may have con-
tributed slightly to error in  PCRnorm). Another, inherent limitation in predicting PCR is 
presented by variability in right–left shunting (including physiological shunting) which 
could not be accounted or corrected for [26]. Finally, it is also important to acknowl-
edge that these results are specific for the energy window settings used on systems with 
an ~ 10% energy resolution, and using  [99mTc]Tc-Technegas, which has minimal early 
clearance after ventilation [27]. Is not clear how changes in these acquisition setting or 
of the ventilation agent used, might affect the reliability of the model.
Conclusion
The expected perfusion count rate for a given dose of  [99mTc]Tc-MAA can be linearly 
predicted by the ratio of ventilation counts in two adjacent energy windows. This rela-
tionship allows for the application of a simple tool to predict and/or optimise the final 
P/V ratio. In addition to the practice of directly monitoring count rate increases during 
 [99mTc]Tc-MAA injection, this tool may assist in optimising the trade-offs between study 
quality,  [99mTc]Tc-MAA dose, and patient turnaround time while still achieving diagnos-
tic quality VP SPECT studies.
Supplementary Information
The online version contains supplementary material available at https:// doi. org/ 10. 1186/ s40658- 021- 00417-z.
Additional file 1: Fig 1 Diagnostic plots of initial training dataset. a Scatter plot of observations in which Eratio 
represents the calculated ratio between acquired counts in the primary energy window divided by the down-scatter 
window on the ventilation study and PCRnorm represents the perfusion count rate per megabecquerel of adminis-
tered [99mTc]Tc-MAA (cps/MBq), normalised to a camera-collimator sensitivity of 1 cps/MBq. b Chart of standardised 
residuals identified an obvious outlier (observation 223), which was also shown to be highly influential on c Cooks’ 
distance chart. Investigation of this observation identified an obvious cause (Figure 2), and on this basis the case was 
excluded, and the regression repeated. Images generated in RStudio.
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Additional file 2: Fig 2 Reconstructed ventilation SPECT of participant 223 (anterior and lateral projections), exhibit-
ing high amount of extracorporeal radiopharmaceutical (red crosshair), very likely on the basis of collimator/detector 
contamination, resulting in an unreliable Eratio value. This participant was excluded from the final analysis. Image 
generated in Hermes Hybrid Viewer PDR 4.0.1 with linear BW inverse colour table, relative scaling.
Additional file 3: Fig 3 Diagnostic plots of final training dataset, exhibiting a linearity of the data, b normality of the 
residuals, c homogeneity of variance, and d outlier observations and points with high leverage. Abbreviations: lm: 
linear model; PCRnorm: normalised perfusion count rate; Eratio: energy window count ratio of the ventilation study. 
Images generated in RStudio.
Additional file 4: Fig 4 Q-Q (top row) and density (bottom row) plots of the residuals (linear regression of PCRnorm 
on Eratio), for the training (left), validation (middle) and combined (training+validation, right) datasets. Results illus-
trate the close adherence to normal distribution of the residuals and support the use of parametric methods to build 
a prediction tool using the training dataset. Images generated in RStudio.
Additional file 5: Fig 5 Scatter plots illustrating the relationship between body habitus (body mass index—BMI) and 
Eratio (a), as well as that Eratio values for any individual subject on V SPECT and VP SPECT are equal (R2 = 0.98) (b). 
The straight line indicates points for which Eratio values calculated on the two studies are equal. Images generated 
in RStudio.
Additional file 6. Perfusion adequacy prediction tool.
Additional file 7. Explanatory video.
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